ERBB2 and breast carcinoma: Two studies found significant correlations between longer telomeres and breast cancer risk [4]; [5], while others found non-significant correlations between shorter telomeres and breast cancer risk [6]–[10] or only significant associations in more aggressive subtypes (HER-2-positive and triple-negative tumors) [11].